3Q22 Financial Highlights
O C T O B E R 1 7 , 2 0 2 2
3Q22 Financial Highlights
Revenue | EPS | ||
Reported | Excluding | Reported | Excluding |
notable items | notable items | ||
(a) | $0.39 | (a) | |
$4,279mm $4,242mm | $1.21 |
Pre-tax income | Pre-tax margin | ||
Reported | Excluding | Reported | Excluding |
notable items | notable items | ||
$630mm | (a) | 15% | (a) |
$1,307mm | 31% |
- Revenue up 6% YoY, up 5%(a) excluding the impact of notable items
- Fee revenue down 1% YoY
- Net interest revenue up 44% YoY
- Expense up 26% YoY, up 4%(a) excluding the impact of notable items
- Recorded a $680mm non-cash goodwill impairment charge(c)
- Provision for credit losses was a benefit of $30mm compared to a provision benefit of $45mm in 3Q21
Returns | Capital ratios | • | Average loans up 11% YoY and down 1% QoQ | |
Reported | Excluding | |||
notable items | • | Average deposits down 10% YoY and down 7% QoQ | ||
ROE: 3.5% | 10.9%(a) | T1L: 5.4%(c) | ||
(b) | (a) | CET1: 10.0%(c) | • | Returned $0.3bn to common shareholders in dividends |
ROTCE: 7.5% | 22.4% |
- Represents a non-GAAP measure. See pages 14 and 15 in the Appendix for the corresponding reconciliation of the non-GAAP measures of revenue, revenue growth, expense growth, pre-tax income, earnings per share, pre-tax margin, ROE and ROTCE excluding notable items.
- Represents a non-GAAP measure. See page 17 in the Appendix for the corresponding reconciliation of the non-GAAP measure of ROTCE.
- (c) Impairment of goodwill associated with the Investment Management reporting unit, which was driven by lower market values and a higher discount rate. This goodwill impairment represents a non-cash charge and did not affect BNY Mellon's liquidity position, tangible common equity or regulatory capital ratios.
3Q22 Financial Results
3Q22 vs.
$mm, except per share data or unless otherwise noted | 3Q22 | 2Q22 | 3Q21 | 2Q22 | 3Q21 | |||||||
Fee revenue | $3,236 | $3,339 | $3,265 | (3)% | (1)% | |||||||
Investment and other revenue | 117 | 91 | 129 | N/M | N/M | |||||||
Net interest revenue | 926 | 824 | 641 | 12% | 44% | |||||||
Total revenue | $4,279 | $4,254 | $4,035 | Down 1%(c) | 1% | Up 4%(c) | 6% | |||||
Provision for credit losses | (30) | 47 | (45) | N/M | N/M | |||||||
excluding | excluding | |||||||||||
notable | notable | |||||||||||
Noninterest expense | 3,679 | 3,112 | 2,918 | items | 18% | items | 26% | |||||
Income before income taxes | ||||||||||||
$630 | $1,095 | $1,162 | (42)% | (46)% | ||||||||
Net income applicable to common shareholders | $319 | $835 | $881 | excluding | (62)% | excluding | (64)% | |||||
Up 5%(c) | Up 11%(c) | |||||||||||
EPS | $0.39 | $1.03 | $1.04 | notable | (62)% | notable | (63)% | |||||
items | items | |||||||||||
Avg. common shares and equivalents outstanding (mm) - diluted | 815 | 814 | 849 | - | |
Operating leverage(a) | Excluding | N/M | |||
notable items | 15% | 26% | 29% | ||
Pre-tax margin | 31%(c) | ||||
ROE | 10.9%(c) | 3.5% | 9.3% | 8.8% | |
ROTCE(b) | 22.4%(c) | 7.5% | 19.2% | 16.8% |
+115 bps(c)
excluding
notable
items
(4)%
N/M
Notable items impacting the quarter
Increase / (decrease) | Revenue | Expense | EPS | |
3Q22 | 37 | 714 | $(0.81) | Impact of goodwill impairment, a disposal gain, severance expense and litigation reserves |
2Q22 | - | 103 | $(0.12) | Impact of higher litigation reserves |
3Q21 | 9 | 73 | $(0.05) | Impact of litigation reserves, gains on disposals and severance expense |
- Note: See page 12 in the Appendix for corresponding footnotes.
- Represents a non-GAAP measure. See page 17 in the Appendix for the corresponding reconciliation of the non-GAAP measure of ROTCE.
- (c) Represents a non-GAAP measure. See pages 14 and 15 in the Appendix for the corresponding reconciliation of the non-GAAP measures of expense growth, earnings per share, operating leverage, pre-tax margin, ROE and ROTCE excluding notable items.
N/M - not meaningful.
Capital and Liquidity
3Q22 | 2Q22 | 3Q21 | |
Consolidated regulatory capital ratios:(a) | |||
Tier 1 leverage ratio | 5.4% | 5.2% | 5.7% |
Supplementary leverage ratio ("SLR") | 6.3 | 6.2 | 7.0 |
Common Equity Tier 1 ratio - Advanced Approaches | 10.1 | 10.0 | 11.8 |
Common Equity Tier 1 ratio - Standardized Approach | 10.0 | 10.1 | 11.7 |
Consolidated regulatory liquidity ratios: | |||
Liquidity coverage ratio ("LCR") | 116% | 111% | 111% |
Cash dividends per common share | $0.37 | $0.34 | $0.34 |
Common stock dividends ($mm) | $303 | $279 | $296 |
Common stock repurchases ($mm) | 2 | 3 | 2,001 |
Book value per common share | $43.18 | $44.73 | $47.30 |
Tangible book value per common share(b) | 21.55 | 22.02 | 24.88 |
Common shares outstanding (mm) | 808 | 808 | 826 |
- Note: See page 12 in the Appendix for corresponding footnotes.
Net Interest Revenue and Balance Sheet Trends
N e t I n t e r e s t R e v e n u e
( $ m m )
+44%
+12%
926
824
641
3Q22 vs. | |||||||
$bn, avg. | 3Q22 | 2Q22 | 3Q21 | ||||
Deposits: | |||||||
Noninterest-bearing | $85 | (8)% | (1)% | ||||
Interest-bearing | 204 | (7)% | (13)% | ||||
Total deposits | |||||||
$288 | (7)% | (10)% | |||||
Interest-earning assets: | |||||||
Cash and reverse repo | 131 | (10)% | (17)% | ||||
Loans | 68 | (1)% | 11% | ||||
Investment securities: | |||||||
HQLA | 121 | (2)% | (4)% | ||||
Non-HQLA | 27 | (3)% | (9)% | ||||
Total investment securities | $148 | (2)% | (5)% |
3Q21 | 2Q22 | 3Q22 |
- Net interest revenue of $926mm up 12% QoQ, primarily reflects higher interest rates on interest-earning assets, partially offset by higher funding expense
Total interest-earning assets | $352 | (5)% | (8)% |
- Avg. deposits of $288bn down 7% QoQ
- Avg. interest-earning assets of $352bn down 5% QoQ
5
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
The Bank of New York Mellon Corporation published this content on 13 January 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 January 2023 11:49:11 UTC.